How the Pope’s Magnifica Humanitas offers a template for individuals to meet the AI moment

Pope Leo XIV’s new encyclical on artificial intelligence includes a statement that warrants serious attention from technologists and policymakers: “Technology is never neutral.” Magnifica Humanitas (“Magnificent Humanity”) is a clarion call to all people to act with courage and solidarity as we enter an age already being transformed by artificial intelligence, the greatest change in human life since the Industrial Revolution. As the pope says, the choice before us—the choice AI presents—is one between the Tower of Babel and the rebuilding of our common humanity. 

In the biblical story of the Tower of Babel, humans sought to build a massive structure that reached all the way to Heaven, only to have their project thwarted when God made those involved unable to understand one another. It was a pursuit fixated on relentless growth, divorced from any concern about God’s commandments or the human cost. It resulted in failure and atomization.

The Book of Nehemiah, however, offers a contrasting narrative, in which the rebuilding of Jerusalem after a period of violence and displacement becomes an opportunity for humanity to show its collaborative resilience. As the encyclical puts it, “The city is reborn, not through the initiative of one man, but through the shared responsibility of all: men, women, priests, artisans, heads of households and young people all play a part. It is an undertaking with God at the center, which rebuilds relationships before rebuilding with stones.” 

Is there any question which road we are currently barreling down? And can there be any doubt which we would do well to walk together? 

We are both Catholics, members of religious communities and longtime advocates within the movement for socially responsible investment. Of particular interest to us and that movement is Pope Leo’s point that AI is not some force of nature or hyperrational, ineffable entity. Instead, he reminds us, AI is ultimately another commercial product, one emerging at a point in history when excessive power over commerce and the wider society has amassed in a vanishingly small number of hands. 

It’s a powerful message. It’s also one that institutional investors have been acting on for years. This encyclical doesn’t break new ground so much as ratify a governance effort that’s already underway, led not by states or international bodies but by shareholders. When governments fail to meaningfully regulate, and corporations cannot be trusted to do what is beneficial beyond their own bottom line, people in society still have the power to set us on the right path, and indeed have the duty to do so. 

Around the world, AI systems are being deployed at scale with remarkably little institutional oversight. There is no AI safety board. The US Federal Trade Commission has jurisdiction over unfair practices but limited authority over algorithmic design. The National Institute of Standards and Technology publishes guidance that most companies ignore. The EU AI Act is partially in force but addresses only a sliver of the deployment surface.

Institutional investors have stepped into this vacuum. Coalitions including the membership of the Interfaith Center on Corporate Responsibility, representing investors managing over $400 billion in assets, have spent the past several proxy seasons filing resolutions demanding transparency, risk assessment, and accountability around AI deployment. Secular institutional investors have joined them, treating AI governance failures as material business risks.

Shareholders have called tech giants including Alphabet, Amazon, Nvidia, Palantir, and Uber to account and demanded that AI not be used for acts of violence or other violations of human rights. The importance of this aspect of corporate governance was highlighted tragically in the opening hours of the war against Iran, when AI was used to help identify targets for thousands of missile strikes that killed hundreds of people.  

Investors have also challenged executives at CVS and UnitedHealth Group to ensure that AI not be used to undermine the well-being of patients and quality of health care across the United States. 

At companies including Meta and Microsoft, shareholders have decried the environmental impact of AI data centers, which consume vast amounts of energy and precious water resources, and in turn can emit large amounts of greenhouse gases. 

Within creative industries, investors have challenged the leadership at companies like Disney, Netflix, and Warner Bros. to demand transparency about the ways they are using AI and to defend the inimitable human element in storytelling. 

Soon, with OpenAI, Anthropic, and Grok all set to enter the public markets, we will be able to exert similar influence over what are now all privately held entities.

These actions by concerned investors not only call out misdeeds but hold fast to an immutable truth: that it is wrong to use technology to kill, harm, or oppress people. Every human being has a right to safe and effective health care and the opportunity to earn a dignified living. The stories we tell each other matter and require the human creative spark. 

Investor advocates hail from a range of faith traditions. Some have no formal religious faith. Yet in their informed and tenacious advocacy, all these people echo the calls embedded within Pope Leo’s encyclical and act on its declaration that “it is essential that the use of AI, especially when it touches on public goods and fundamental rights, be guided by clear criteria and effective oversight.” 

Encyclicals mark time. A century from now, how will we be remembered for how we met this moment? Will we be seen as having been too timid or shortsighted to prevent a small group of unfathomably wealthy and self-interested people from seizing ever greater control over the human family’s shared destiny? 

Or will the years ahead be remembered as a turning point that helped us rebuild our common humanity? Let this be a time when people of good will and diverse talents come together through their own magnificent humanity to build a future that honors our Creator.

Father Séamus Finn, OMI, is a global leader in faith-based and socially responsible investing and a priest of the Oblates of Mary Immaculate, a missionary religious congregation.

Sister Susan Francois is the assistant congregation leader and congregation treasurer for the Sisters of St. Joseph of Peace.

Trelleborg breaks ground on Minnesota Innovation Center expansion

Trelleborg Medical Solutions announced today that it broke ground on its Innovation Center expansion in Delano, Minnesota. Plymouth, Minnesota-based Trelleborg announced its plans to expand in Delano last summer. It aims to expand the footprint of the site to take on additional projects and accelerate the design and development cycle for customers. The project includes…

The post Trelleborg breaks ground on Minnesota Innovation Center expansion appeared first on Medical Design and Outsourcing.

The Download: climate tech goes public and the AI Hype Index returns

This is today’s edition of The Download, our weekday newsletter that provides a daily dose of what’s going on in the world of technology.

Climate tech companies are going public. What’s next?

Solar and battery company Solv Energy went public in February, hitting a $6 billion valuation. X-energy, which builds small modular nuclear reactors, followed at $11.5 billion. Then came geothermal company Fervo Energy, reaching a market cap of about $12.4 billion.

All three have been IPO success stories. And it doesn’t feel like a coincidence that they’re racing to provide electricity in an era of rising demand, driven partly by data centers.

What does this boom reveal about the future of the grid? And what comes next? Read the full story to find out.

—Casey Crownhart

This story is from The Spark, our weekly newsletter giving you the inside track on all things climate. Sign up to receive it in your inbox every Wednesday.

The AI Hype Index

Separating AI reality from hyped-up fiction isn’t always easy. That’s why we’ve created the AI Hype Index—a simple, at-a-glance summary of what’s shaping the industry right now.

The latest edition includes billionaire road trips, students booing, made-up quotes, and too much sci-fi. See where it all landed on this month’s index.

The must-reads

I’ve combed the internet to find you today’s most fun/important/scary/fascinating stories about technology.

1 Illinois just passed what could become America’s strongest AI safety law
It would require third-party safety audits. (Wired $)
+ But it still needs the governor’s approval. (NBC News)
+ The US is divided over AI regulation. (MIT Technology Review)

2 A Google engineer has been charged with insider trading
He allegedly bet on who’d be the most-searched people of 2025 on Polymarket. (BBC)
+ And used internal data to rack up more than $1.2 million in winnings. (Verge)
+ He’s been charged with fraud and money laundering over the bets. (NPR)

3 ByteDance is developing custom CPUs amid a massive AI chip squeeze
The TikTok owner is struggling with severe supply shortages. (Reuters $)
+ Google, Amazon, and Microsoft are also building custom CPUs. (CNBC)
+ Taiwan’s “silicon shield” could be weakening. (MIT Technology Review)

4 Four tech giants have backed a clean energy push for AI data centers
Amazon, Google, Meta, and Microsoft have joined the initiative. (Quartz)
+ Investor Elemental Impact will deploy up to $5 million per project. (Axios)

5 Nvidia’s CEO is joining the board of Beijing’s Tsinghua University
His appointment comes as Nvidia struggles to export chips to China. (FT $)
+ President Xi is an alumnus of Tsinghua, aka “China’s Harvard.” (Reuters $)

6 The Trump administration is in talks to fund drone firms
One of which counts Donald Trump Jr. as a shareholder. (WSJ $)
+ Drone dominance has been described ​as a “presidential priority.” (Reuters $)

7 London has reclaimed its position as Europe’s leading tech hub
It’s overtaken Paris in new global rankings. (Euronews)
+ And now sits fourth, behind the Bay Area, New York and Boston. (Reuters $)

8 OpenAI and Anthropic disagree over AI’s impact on jobs
Anthropic is emphasizing the risks, while OpenAI is sounding rosier. (Axios)
+ The AI jobs hysteria needs a reality check. (MIT Technology Review)

9 Researchers claim to have achieved perfect randomness for the first time
Thanks to entangled quantum chips. (Interesting Engineering)
+ The milestone could lead to better cybersecurity. (Scientific American)

10 Embryo organoids are showing why many pregnancies fail
They’ve led to improvements in IVF and pregnancy treatments. (New Scientist $)
+ New tech is transforming reproductive medicine. (MIT Technology Review)

Quote of the day

“How can we be happy about Google coming? We’ll all be scattered. It feels very sad.”

—Pyla Kondamma, a 42-year-old in Visakhapatnam, India, tells the Wall Street Journal her concerns about Google building data centers in her city.

One More Thing

NICO ORTEGA


Why venture capital doesn’t build the things we really need

Venture capital has been the engine of US innovation for years. This largely white, largely male corner of finance has backed software companies that grow fast—but generate large amounts of money for a shrinking number of Americans.

It’s also creating fewer jobs for ordinary people. And recently, venture capitalists have struggled to find ideas that fit their preferred pattern.

Here’s what’s going wrong with the funding model that made Silicon Valley a global hub.

—Elizabeth MacBride

We can still have nice things

A place for comfort, fun, and distraction to brighten up your day. (Got any ideas? Drop me a line.)

+ Never miss a great movie again with this worldwide release tracker.
+ These quirky word puzzles use emoji hints to help you find answers.
+ The digital museum of plugs and sockets is a treasure trove of global connectors.
+ Michael Jackson’s “Smooth Criminal” becomes a Bach-style fugue played on classical guitar.

Detecting Alzheimer’s Early by Brain Scan or Blood

While Alzheimer’s disease accounts for about 60-70% of dementia diagnoses, the timing of these diagnoses occur late in disease progression. Identifying early signs of Alzheimer’s may allow individuals time to address potential risk factors in their lives.

“Alzheimer’s disease pathology begins years before symptoms emerge,” said Kristine Yaffe, MD, vice chair in the UCSF Department of Psychiatry and Behavioral Sciences. Yaffe and her team have spent years researching modifiable risk factors that may play a role in dementia development, including physical and cognitive activity, depression, smoking, and cardiovascular health.

A current trajectory of research into Alzheimer’s disease is focusing on ways to detect the disease early, before major symptoms manifest. Two new studies published in The Lancet present different methods for detecting Alzheimer’s disease that converge in their early detection ability.

Alzheimer’s disease is characterized by increased amounts of tau and amyloid-β plaques. Growing research indicates the importance of tau pathology and amyloid-β  accumulation at initiating changes to the brain associated with Alzheimer’s disease.

“Tau is the biology most closely tied to symptoms and future decline,” said Tharick Pascoal, MD, PhD, associate professor of psychiatry and neurology at the University of Pittsburgh and a behavioral neurologist at University of Pittsburgh School of Medicine. “If we can detect tau earlier and stage it more precisely, we can make better decisions about who is truly on an Alzheimer’s trajectory, which matters for clinical trials now and could shape clinical decision-making as new therapies emerge.”

Researchers at the University of Pittsburgh led by Guilherme Povala, PhD, and Bruna Bellaver, PhD, have focused their work on brain scan imaging to detect tau both more effectively, and earlier.

The team’s recently published work compared the ability of two tracers used in non-invasive PET scans to visualize Alzheimer’s-associated tangles of tau protein. To do this, participants underwent paired tau PET scans, the first using a standard tau tracer, Flortaucipir, or a new tracer, MK6240. Within 45 days of the PET scan, participants also received an amyloid-β PET scan and detailed cognitive assessments. Of the 775 initial participants, 682 completed all of the study components.

“Because participants received both tracer scans within a short window, we’re looking at the same moment in the disease course, so differences we see reflect the tracers, not changes over time,” explained co-lead author, Guilherme Povala, PhD, postdoctoral associate at the University of Pittsburgh, about the experimental design.

Analysis showed that imaging with the MK6240 tracer detected more tau than tracing with Flortaucipir. In participants with cognitive impairment and positive amyloid-β results, MK6240 identified move than twice as many tau-positive cases, 15% compared with six percent, which was an additional 23 patients per 100. Tracing with MK6240 also identified increased tau, 28% vs. 16% with Flortaucipir, in patients with mild cognitive impairment and dementia, resulting in 15 or 21 additional cases per 100 participants scanned.

“People typically seek evaluation because they have memory concerns or other symptoms,” pointed out co-lead author, Bruna Bellaver, PhD, research assistant professor of psychiatry at the University of Pittsburgh. “Tau PET is one tool that can help clinicians stage disease biology and make more informed decisions.”

Across the country in California, researchers from University of California, San Francisco, have drawn on their experience with blood biomarkers in an effort to develop a method for detecting Alzheimer’s before major symptoms develop.

The west coast study included 1,350 participants (out of an initial 2248) who were retained in the U.S. Coronary Artery Risk Development in Young Adults (CARDIA) study. Participant blood plasma was tested from samples that were collected at project year 35 (2020-2022) and five years prior. Plasma biomarkers for amyloid-β (Aβ42 and Aβ40) and tau (p-tau217) were measured and used to calculate p-tau217-to-Aβ42 and Aβ42-to-Aβ40 ratios and then those were compared to the cognitive assessment scores that were measured at the same time period. Any participants missing materials were excluded from the initial cohort. During analysis, participants were also classified by Alzheimer’s disease neuropathy status of negative, intermediate and positive based on amyloid PET-validated cutpoints for each marker.

Results from the initial analysis showed that participants with high biomarkers also had both lower processing speeds and lower executive function in the first time point. After five years, the group that initially had high levels of biomarkers now had a 2.5 to 4 times increased risk of rapid decline in verbal memory, and three to four times the risk for rapid decline in processing speed. Together, these data suggest a connection between the observed cognitive decline and increase in biomarkers.

While brain scans, and spinal fluid tests are often used and widely available, blood tests are less invasive and relatively inexpensive, potentially enabling more patients access to diagnostics along with early detection prior to symptom development. While there is potential for measuring blood biomarkers for clinical use, senior author, Yaffe, prescribes cautious optimism. “There’s a possibility of false positives and [these markers] can only be used for Alzheimer’s, not other dementias, meaning about 60% to 70% of all dementia cases,” she said. “But for some people who discover they have the biomarkers, testing could open a window to embark on interventions that may postpone Alzheimer’s onset.” More work is still needed to clarify the utility of both early detection methods in the clinic.

Overall, both studies show significant progress in developing strategies to identify dementia, and specifically Alzheimer’s disease, earlier. Earlier diagnosis may lead to earlier intervention and potentially more positive outcomes for patients. As Yaffee concluded, “Detecting the disease early means patients can target modifiable risk factors and maybe seek other care.”

The post Detecting Alzheimer’s Early by Brain Scan or Blood appeared first on Inside Precision Medicine.

Negative Online Experiences Are Common but Often Go Unreported Among Youth With Mental Health and Neurodevelopmental Concern

New Child Mind Institute study finds more than one in four youth experienced a negative online experience in the past year, yet only one in five reported the incident through platform tools.

New York, NY — A new study from researchers at the Child Mind Institute finds that negative online experiences are common among children and adolescents with mental health and neurodevelopmental conditions, and that most incidents are not reported through platform reporting tools.

Published in JAACAP Open, the study examined negative online experiences among 1,009 youth ages 9 to 15 with a history of mental health or neurodevelopmental concerns, all of whom were current or previous participants in the Child Mind Institute’s Healthy Brain Network. More than one in four reported at least one negative online experience in the past year. Among those who had such an experience, nearly 69% reported multiple incidents, yet only 20% reported the incident through platform reporting tools.

The study defined “negative online experience” as any unwanted or uncomfortable experience while online, including cyberbullying, cyberstalking, doxxing, impersonation, sexual harassment, and related forms of digital harm. The research used a mixed-methods design, combining a quantitative survey with an in-depth qualitative follow-up involving a three-day moderated online bulletin board with a subset of participants.

“These findings point to a large and often hidden problem,” said Michael P. Milham, MD, PhD, Chief Science Officer at the Child Mind Institute and senior author of the study. “Many young people are encountering harmful or uncomfortable experiences online, but the systems designed to help them often do not receive a report. That creates a major gap for parents, educators, clinicians, and platforms trying to keep children safer online.”

The research team identified three major categories of barriers that prevent youth from reporting negative online experiences: reporting process barriers, such as not knowing how to make a report; reporting policy barriers, including uncertainty about what qualifies for reporting or how platform rules apply; and emotional barriers, such as embarrassment, fear, and worry about consequences.

The study also found that reporting decisions were often shaped by how young people interpreted the incident itself. In the qualitative follow-up, youth considered whether the harmful behavior seemed intentional, how malicious it appeared, and how severe or repeated the harassment was. When those cues were ambiguous, youth were less certain about whether reporting was appropriate.

“Reporting is not simply a matter of telling young people to speak up,” said Mirelle Kass, lead author of the study. “Youth are making complicated judgments about intent, severity, platform rules, and the possible consequences of disclosure. If we want young people to report harmful experiences, the tools and systems around them need to be clearer, safer, and easier to use.”

The findings suggest that online safety efforts should be tailored to the needs of youth who may already be managing mental health, developmental, or social challenges. Social aptitude, mental health symptoms, and parenting style were associated with youths’ likelihood of encountering negative online experiences and with the barriers they faced when deciding whether to report them.

Participants also expressed a clear desire for better tools and guidance. Most youth wanted platforms to provide more information about how to protect themselves online, how to use safety features such as blocking and reporting, and how to access support during and after the reporting process.

“Families, educators, clinicians, policymakers, and technology developers all have a role to play,” said Dr. Milham. “We need reporting systems that children can understand, policies that are transparent, and trusted adults who can respond without blame or overreaction. Safer digital spaces will require more than awareness. They will require systems designed around how young people actually experience online harm.”

The study underscores the importance of developmentally appropriate safety tools, clearer platform policies, and stronger support systems for youth navigating digital spaces. For children and adolescents with mental health and neurodevelopmental conditions, improving reporting pathways may be an important step toward reducing hidden online harms and building safer online environments.

This research was supported by funding from Google LLC’s User Safety team to the Child Mind Institute for work led by Michael P. Milham, MD, PhD.


About the Healthy Brain Network

The Healthy Brain Network is a community-centered research initiative from the Child Mind Institute that collects clinical, cognitive, behavioral, and neurobiological data from children and adolescents in the New York City area. Families who participate receive feedback and diagnostic consultation while contributing to open science research aimed at improving understanding of child and adolescent mental health.

About the Child Mind Institute

The Child Mind Institute is an independent nonprofit organization dedicated to transforming the lives of children and families struggling with mental health and learning disorders. Through cutting-edge research, evidence-based clinical care, and public education, the Child Mind Institute builds open science platforms and digital tools to accelerate discovery and improve youth mental health worldwide.

For press questions, contact cmiscience@ssmandl.com or mediaoffice@childmind.org.

The post Negative Online Experiences Are Common but Often Go Unreported Among Youth With Mental Health and Neurodevelopmental Concern appeared first on Child Mind Institute.

Recruitment and Participation of Black Home Health Care Patients in Speech-Based Cognitive Research: Mixed Methods Feasibility Study

Background: Older Black adults remain underrepresented in dementia research, particularly in studies using speech-based methods for early cognitive assessment. Understanding how to effectively recruit and engage this population in research involving audio-recorded interactions is critical to ensuring equitable inclusion and developing culturally responsive study designs. However, recruiting older Black adults into dementia research remains a significant challenge. Objective: This study assessed the feasibility of recruiting older Black home health care (HHC) patients into speech-based cognitive research and examined the factors influencing participation and participants’ data collection experiences. Methods: We conducted a convergent mixed methods feasibility study using a 4-component recruitment pipeline at a nonprofit HHC agency: (1) patient identification and study introduction, (2) in-home audio-recorded cognitive assessments, (3) follow-up calls, and (4) audio-recorded patient-clinician encounters. Both patients and their corresponding clinicians were included in this study. Eligible participants were Black adults aged 60 years and older receiving HHC services in New York City. Patient demographic and clinical characteristics were compared between those who consented and those who declined using bivariate analysis. Qualitative feedback was gathered through patient questionnaires and clinician semistructured interviews and was analyzed using reflexive thematic analysis. Results: Of 246 patients contacted, 71 (28.9%) provided verbal consent and 60 (24.4%) completed cognitive assessments. Five patients were excluded due to health conditions or severe cognitive impairment, leaving 55 eligible participants. Among these participants, retention remained high across study components, including follow-up calls (48/55, 87.3%) and audio-recorded clinician visits (54/55, 98.2%). Patients who did not consent were more likely to have greater complex medical profiles, including higher pain interference (=.01), need for assistance with medication reading (=.04), and polypharmacy (≥5 medications; =.01), while no significant differences were observed for age, gender, or functional status. Qualitative findings demonstrated high acceptability and feasibility of audio recording. Patients reported strong motivation to participate, positive and engaging experiences, comfort with recording, and minimal disruption to care. Clinicians reported ease of integration into workflow, initial discomfort that diminished over time, minor technical challenges, and perceived benefits for communication and patient engagement. Conclusions: Recruiting Black older adults receiving HHC into speech-based dementia research was feasible and well accepted. Culturally tailored recruitment may enhance equitable participation and guide future research using audio-recorded speech for early cognitive detection.
<img src="https://jmir-production.s3.us-east-2.amazonaws.com/thumbs/b5818e122d1c9d95d1dad3f3e7fea9cc" />

STAT+: As Ebola outbreak in Central Africa grows, the U.S. turns itself into a fortress

When Craig Spencer contracted Ebola while working in Guinea during the West African outbreak in 2014, he was already back in the United States when he first developed symptoms. He credits the treatment he got at New York’s Bellevue Hospital for his survival.

If Spencer, an emergency medicine physician and an associate professor in Brown University’s School of Public Health, were to contract Ebola in the current outbreak in the Democratic Republic of Congo and Uganda — if he’d even had high-risk exposures to Ebola patients — he wouldn’t be allowed back into the U.S. for care or quarantine.

Administration officials confirmed Thursday that any Americans who contract Ebola will not be brought to the United States for treatment. Instead, they will be evacuated to as-yet-undetermined locations in Europe. An official, speaking on condition of anonymity, told reporters that the Centers for Disease Control and Prevention and the State Department are working to identify tertiary care facilities that could take Americans needing care. One such case has already occurred.

Continue to STAT+ to read the full story…

STAT+: Biotech veteran Jeremy Levin on why the industry’s future is secure, but American leadership is at risk

Biotech is producing scientific breakthroughs that once seemed impossible. But according to longtime industry executive Jeremy Levin, the institutions that support these advances, from regulators, to investors, and even public trust in science itself — are beginning to fracture.

Levin is the founder and chairman of Ovid Therapeutics and former CEO of Teva Pharmaceuticals. In his new book, “Biotech in the Balance: Saving a Strategic Industry in an Age of Distrust,” he argues that political upheaval, weakening institutions, short-term investing, and more are putting the future of the industry at risk, even though the science itself continues to accelerate.

On this week’s episode of “The Readout Loud,” Levin advocates for federal changes that could incentivize biotech investment, and for pharmaceutical companies, in particular, to call out how regulatory upheaval is harming the drug industry. “When an institution such as this, which is critical, is shaken, the industry must stand firm. It must call out why this is a problem. … The titans are dead silent right now,” he said. 

Below are highlights from his conversation with hosts Elaine Chen, Adam Feuerstein, and Allison DeAngelis.

This transcript of the interview has been lightly edited for length and clarity.

Continue to STAT+ to read the full story…

How a new extraction process could unlock the world’s lithium

Researchers say they’ve found a new way to extract lithium, a crucial metal used in the lithium-ion batteries that power electric vehicles and energy storage arrays. This new technique could be more environmentally friendly and cheaper than existing ones. 

The research was published today in Science, and a startup called Rock Zero is working to commercialize the process.

“At scale, we believe this will be the lowest-cost way of sourcing lithium in the world,” says Yet-Ming Chiang, one of the study authors, who is an MIT professor and a serial entrepreneur behind climate tech companies including Form Energy and Addis Energy.

The most economical way to get lithium currently is to extract it from brine, salty water that’s pulled the metal out of rock over the course of millennia. But this technique is geographically limited and currently requires vast tracts of land for massive evaporation pools. The more common tactic is hard-rock mining, where large bodies of ore are blasted apart, cooked at high temperatures, and processed using dangerous chemicals.

The researchers’ new method uses a weak acid to dissolve typically nonreactive silicate minerals. That frees not only the lithium but also other useful materials, including alumina and silica.

The origin story for this research, and the resulting company, came from another startup founded by Chiang, Sublime Systems, which makes cement using electrochemistry.

The team was trying to find a source of highly reactive silica in order to form stronger cement. One way to make reactive materials, which can bond easily with other materials, is to take a nonreactive material, dissolve it, and then allow it to become solid in a more reactive form. It’s not impossible to dissolve silicates, but the best-known way is to use hydrofluoric acid, an extremely dangerous chemical. Other fluorine-containing chemicals are candidates too, but some will produce hydrofluoric acid as a side product during reactions. 

Chiang drew inspiration from a previous home renovation project involving glass, which is made of silica. “I was remodeling a shower in Framingham, Massachusetts, about 25 years ago,” he says. “So when we started this project, I remembered that glass etching cream and thought, ‘What’s in that?’” 

The glass etching cream he remembered, which can be found on shelves at any craft or home improvement store, uses ammonium fluoride, a weak acid. And the MIT researchers discovered that in the right conditions, it can effectively dissolve silicate minerals without producing hydrofluoric acid in the process.

This chemistry could be useful for any silicate minerals—and there are a lot of them. But spodumene, the mineral that’s often mined for lithium, became a prime first target. (Chiang says a suggestion from Doug Wicks, one of the company’s advisors and a former ARPA-E official, pointed the team in spodumene’s direction.)

small pieces of rock next to a line of 3 capped vials of powder
From left to right: spodumene, silica, alumina and lithium salts.
ROCK ZERO

Today, a key step in processing spodumene ore is to roast it in a kiln at super-high temperatures. This causes a phase transformation, essentially puffing up the material and making the lithium more accessible.

By avoiding the need to reach these temperatures, you could save on energy costs and potentially reduce carbon emissions as well, says Camden Hunt, one of the authors of the study and the CEO and cofounder of Rock Zero.

Avoiding the kiln could also unlock the ability to use some ores that can’t be roasted properly, Hunt adds. Ore that contains too much iron won’t go through the phase change correctly, instead melting and turning into a glassy material.

The new process relies on simple stirred plastic tanks and takes place at temperatures up to about 95 °C (200 °F). The ammonium fluoride dissolves the silicates, which in earlier experiments allowed nearly all of the lithium inside the spodumene ore to be extracted within a couple of days. The researchers have since cut this time to under 12 hours, says Benjamin Mowbray, first author of the study and the CTO and cofounder of Rock Zero.  

The products (after some additional steps to clean them up) are lithium carbonate, which can be used to make batteries; alumina, which can go into a smelter to make aluminum; and cementitious silica, which can be added into concrete. And the acid can be reused in the same loop.

Chiang calls this “nose-to-tail” mining—using every part of the ore provided, like eating every part of a butchered animal.

The researchers are currently working to scale and optimize the process. The tanks in the lab in Cambridge, Massachusetts can handle three kilograms of spodumene concentrate in each batch. 

They have also estimated the cost of this process once fully scaled up. Assuming that the ammonium fluoride can be recycled at a high level, they should be able to extract lithium for less than $6,000 per metric ton. (They’ve identified a potential cheap industrial source of the acid as well, as an alternative to recycling it.) 

The total cost is projected to be lower than that of other processes used to extract lithium from hard-rock ore today, and it could be competitive with brine.

The team has designed a pilot plant and is looking for space to build it. The plan is to have construction done by the end of 2026 and start operating the facility in 2027. Talks are underway with potential partners in the mining industry.

One difficulty for new players in lithium extraction is the volatility of the market: Prices have seen huge swings in recent years, from a peak in 2022 to lows in late 2024 and a slow climb starting in early 2026. 

Rising prices might benefit new players like Rock Zero, but there are many projects that could come online if prices continue to rise, and that could bring the market right back down, says Simon Jowitt, chair of exploration geology at the University of Nevada, Reno. “People are waiting to see what happens with the lithium price,” he says. “It’s a crowded market, and there’s some big players out there.”

And even though batteries are driving up demand for lithium, the market is still relatively small, Jowitt adds: “That means it’s going to be volatile.” New lithium extraction technologies like Rock Zero’s will have to compete with methods used by existing giants, and there’s also the potential that technological alternatives, like sodium-ion batteries that don’t need lithium, could make the market more difficult to navigate, Jowitt says. He also thinks some of the company’s economic estimates could be optimistic.

For its part, Rock Zero’s team hopes not only to scale this technology for lithium, but to use it for other minerals in the future. As Mowbray says, “The Earth’s crust is made of silicates.”